QQ客服 官方微博 反馈留言

浏览/检索结果: 共28条，第1-10条 帮助 限定条件 发表日期：2016     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type 期刊论文 FASEB JOURNAL, 2016, 卷号: 30, 期号: 10, 页码: 3388-3399 作者:  Li, Daojing;  Wang, Chunjiong;  Yao, Yang;  Chen, Li;  Liu, Guiyou 收藏  |  浏览/下载：55/0  |  提交时间：2017/03/21 ischemia  glia cells  polarization   Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis 期刊论文 BMC CARDIOVASCULAR DISORDERS, 2016, 卷号: 16 作者:  Meng, M;  Gao, B;  Wang, X;  Bai, ZG;  Sa, RN 收藏  |  浏览/下载：4/0  |  提交时间：2017/01/10 Everolimus-eluting stent  Paclitaxel-eluting stent  Percutaneous coronary interventions  Systematic review  Meta-analysis   RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-vegf cohort subanalysis 会议论文 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Everolimus-Eluting versus Paclitaxel-Eluting Stents in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Meta-Analysis of Randomized Controlled Trials 会议论文 作者:  Zhu Jianbing;  Ge, Junbo 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4) 期刊论文 ANNALS OF ONCOLOGY, 2016, 卷号: 27, 期号: 3 作者:  Motzer, R. J.;  Alyasova, A.;  Ye, D.;  Karpenko, A.;  Li, H. 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 everolimus  metastatic renal cell carcinoma  sequential targeted therapy  second-line  prospective study   RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis. 会议论文 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis 期刊论文 Journal of Clinical Oncology, 2016, 卷号: 34 作者:  Cosgriff T., Yang L., Alyasova A., Ye D., Karpenko A., Li H., Alekseev B., Xie L.-P., Kowalyszyn R.D., Karyakin O., Neron Y.V., Collins L.T., Brechenmacher T., Lin C., Morgan L., Motzer R.J. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 A meta-analysis of randomized controlled trials of bare metal stent versus cobalt-chromium everolimus eluting stents on cardiovascular events 期刊论文 Journal of the American College of Cardiology, 2016, 卷号: 68 作者:  Jianbing Z., Ge J. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-VEGF cohort subanalysis 会议论文 作者:  Morgan, Liza;  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis. 会议论文 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05